Lite Strategy, Inc. (LITS)Healthcare | Biotechnology | San Diego, United States | NasdaqCM
0.98 USD
-0.02
(-1.960%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 0.98 |
Hot Take ↕ | Aug. 22, 2026, 2:46 a.m. EDT
The investment case for Lite Strategy is severely compromised by deteriorating fundamentals and a catastrophic long-term price trajectory. Despite a recent one-off dividend payment, the company is burning through cash, reporting negative free cash flow, and posting massive losses on both assets and equity. The balance sheet, while showing high liquidity ratios, masks the reality of a business that has lost over 87% of its value over the last nine years. The recent share buybacks are a desperate attempt to prop up the per-share metrics for the underlying Litecoin holdings, but they cannot reverse the structural decline evident in the stock price. With no analyst coverage, a negative statistical forecast, and options markets signaling pure fear, this remains a speculative trap for capital preservation. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.096879 |
| MSTL | 0.096959 |
| AutoARIMA | 0.097210 |
| AutoTheta | 0.263238 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 41% |
| H-stat | 0.83 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.167 |
| Excess Kurtosis | 0.22 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Ex Dividend Date | 2023-11-15 |
| Last Dividend Date | 2023-11-15 |
| Market Cap | 33,358,306 |
| Beta | 0.04 |
| Previous Name | MEI Pharma, Inc. |
| Website | https://www.litestrategy.com |
As of Aug. 22, 2026, 2:46 a.m. EDT: Options activity reveals a distinct lack of bullish positioning. Call volume and open interest are negligible across all expirations, with zero in-the-money calls recorded. Conversely, put buyers have established significant open interest at deep out-of-the-money strikes (e.g., 7.5 strike in Dec '26), while ATM puts show notable volume relative to calls. This asymmetry suggests speculators are hedging against downside or betting on continued weakness rather than anticipating a rally.
| Date | Dividend | Yield % |
|---|---|---|
| 2023-11-16 | 1.75 | 28.501629 |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.7938144 |
| Address1 | 9,920 Pacific Heights Blvd. |
| Address2 | Suite 150 |
| All Time High | 15,720.0 |
| All Time Low | 0.69 |
| Ask | 1.25 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 193,940 |
| Average Daily Volume3 Month | 275,445 |
| Average Volume | 275,445 |
| Average Volume10Days | 193,940 |
| Beta | 0.035 |
| Bid | 0.7272 |
| Bid Size | 2 |
| Book Value | 1.617 |
| City | San Diego |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.9804 |
| Current Ratio | 11.528 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 1.02 |
| Day Low | 0.9703 |
| Display Name | Lite Strategy |
| Dividend Date | 1,701,820,800 |
| Earnings Timestamp End | 1,790,598,600 |
| Earnings Timestamp Start | 1,790,598,600 |
| Ebitda | -17,126,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -1.507 |
| Enterprise Value | 25,814,306 |
| Eps Trailing Twelve Months | -2.08 |
| Esg Populated | 0 |
| Ex Dividend Date | 1,700,092,800 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 0.9498 |
| Fifty Day Average Change | 0.030600011 |
| Fifty Day Average Change Percent | 0.03221732 |
| Fifty Two Week Change Percent | -79.38144 |
| Fifty Two Week High | 5.15 |
| Fifty Two Week High Change | -4.1696 |
| Fifty Two Week High Change Percent | -0.80963105 |
| Fifty Two Week Low | 0.69 |
| Fifty Two Week Low Change | 0.29040003 |
| Fifty Two Week Low Change Percent | 0.42086962 |
| Fifty Two Week Range | 0.69 - 5.15 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,071,757,800,000 |
| Float Shares | 31,820,367 |
| Free Cashflow | -13,420,250 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 4 |
| Fullday Change | -0.0196 |
| Fullday Change Percent | -1.96 |
| Fullday Price | 0.9804 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Gross Profits | -1,969,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.01163 |
| Held Percent Institutions | 0.17307 |
| Implied Shares Outstanding | 34,025,200 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Dividend Date | 1,700,092,800 |
| Last Dividend Value | 1.75 |
| Last Fiscal Year End | 1,751,241,600 |
| Last Split Date | 1,681,689,600 |
| Last Split Factor | 1:20 |
| Long Business Summary | Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California. |
| Long Name | Lite Strategy, Inc. |
| Market | us_market |
| Market Cap | 33,358,306 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_2214205 |
| Most Recent Quarter | 1,774,915,200 |
| Name Change Date | 2,026-08-28 |
| Net Income To Common | -60,820,000 |
| Next Fiscal Year End | 1,782,777,600 |
| Non Diluted Market Cap | 34,025,200 |
| Open | 1.0 |
| Operating Cashflow | -10,418,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Peg Ratio | 2.22 |
| Phone | 858 369 7100 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 0.9804 |
| Post Market Time | 1,787,947,805 |
| Prev Name | MEI Pharma, Inc. |
| Previous Close | 1.0 |
| Price Hint | 4 |
| Price To Book | 0.606308 |
| Profit Margins | 0.0 |
| Quick Ratio | 7.924 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.0196 |
| Regular Market Change Percent | -1.96 |
| Regular Market Day High | 1.02 |
| Regular Market Day Low | 0.9703 |
| Regular Market Day Range | 0.9703 - 1.02 |
| Regular Market Open | 1.0 |
| Regular Market Previous Close | 1.0 |
| Regular Market Price | 0.9804 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 102,999 |
| Return On Assets | -0.27686 |
| Return On Equity | -1.59261 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 34,025,200 |
| Shares Percent Shares Out | 0.0046 |
| Shares Short | 156,379 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 118,433 |
| Short Name | Lite Strategy, Inc. |
| Short Percent Of Float | 0.0053 |
| Short Ratio | 1.23 |
| Source Interval | 15 |
| State | CA |
| Symbol | LITS |
| Total Cash | 7,544,000 |
| Total Cash Per Share | 0.222 |
| Total Debt | 0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -2.08 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.19735 |
| Two Hundred Day Average Change | -0.21695 |
| Two Hundred Day Average Change Percent | -0.18119179 |
| Type Disp | Equity |
| Volume | 102,999 |
| Website | https://www.litestrategy.com |
| Zip | 92,121 |